INTRODUCTION: @entity2298 is the third most common cause of acute @entity788 . The current evidence on the management of @entity2298 -induced @entity788 (HTGP) is mainly derived from case series. It has been suggested that insulin, and plasmapheresis have a role in the management of acute HTGP. We present a retrospective review of @entity1 seen at a community-teaching hospital between 2005 and 2015. RESULTS: Out of the 549 admissions for acute @entity788 , fourteen @entity1 met our inclusion criteria. The mean age of presentation was 39   8 years and there was a predominance of @entity1 (57%). More than two-thirds of the @entity1 were admitted to the intensive care unit. The majority of the @entity1 were treated with insulin drip (n=8), and the rest by subcutaneous insulin (n=3) and insulin drip + plasmapheresis (n=3). In the insulin drip group we noted a gradual decrease of the admission serum @entity1674 by 50.6   16.0 % at 24 hours, 65.9  16.9% at 48 hours, and then 85.2   7.1% at discharge. Serum @entity1674 decreased by 79.8% and 92.6%, at discharge in the subcutaneous insulin and insulin + plasmapheresis cohorts, respectively. The insulin + plasmapheresis cohort stayed in the hospital longer (20.7  3.1 days) compared to the insulin drip (10.3  5.4 days) and subcutaneous insulin (5.7    1.2 days) cohorts. CONCLUSION: Our study strengthens the evidence for using insulin (infusion or subcutaneous) with or without plasmapheresis in the treatment of hypertriglycerimia- induced @entity788 . [Full article available at http://rimed.org/rimedicaljournal-2015-12.asp, free with no login].

XXXX -Induced @entity788 : A Decade of Experience in a Community-Based Teaching Hospital.

@entity2298 :: ('MESH:D015228', 'Disease') :: ['Hypertriglyceridemia', 'hypertriglyceridemia'] @entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatitis'] @entity1674 :: ('MESH:D014280', 'Chemical') :: ['triglycerides']
@entity2298 :: (MESH:D015228,Disease) :: ['Hypertriglyceridemia']
